PerkinElmer and Verinata Health have entered a collaboration agreement to distribute the latter’s fetal chromosomal abnormality test. The agreement was announced just a couple of days after San Diego-based genome sequence instrument manufacturer Illumina entered into terms to acquire Verinata for $450 million. Based in Redwood City, Calif., Verinata introduced its chromosome test, known as…
PerkinElmer, Verinata Collaborate on Prenatal Test
PerkinElmer and Verinata Health have entered a collaboration agreement to distribute the latter’s fetal chromosomal abnormality test. The agreement was announced just a couple of days after San Diego-based genome sequence instrument manufacturer Illumina entered into terms to acquire Verinata for $450 million. Based in Redwood City, Calif., Verinata introduced its chromosome test, known as […]